Apheresis Market To Register Incremental Growth At A CAGR Of ~ 8.75% By 2030 Delveinsight
Apheresis Overview Apheresis is a medical technology used to separate various constituents of the blood, in which the remaining components of the blood are returned to the patient after extraction of ...
Cardiac Arrhythmia Monitoring Devices Market To Register Incremental Growth At A CAGR Of ~ 6.33% By 2030 Delveinsight
Key Takeaways from the Cardiac Arrhythmia Monitoring Devices Market Report .On November 13, 2024, SmartCardia received FDA clearance for its Mobile Outpatient Cardiac Telemetry (OCT/MCT) system, which ...
Oncology Nurse Advisor1d
Surveillance for Cutaneous Malignant Neoplasms Recommended in Post-BMT Patients
Researchers explored the risks for basal cell carcinoma, squamous cell carcinoma, and melanoma in patients who underwent BMT.
Clinton Herald2d
TO YOUR GOOD HEALTH: Low iron stores due to thalassemia call for an evaluation
I am Greek and have thalassemia minor. In general, my red blood cells are much smaller than typical ones, and my iron content ...
Cure Today3d
Putting an Emphasis on Patient Collaboration in MPN Treatment
Dr. Richard “Rick" Winneker discussed advice that he would provide to patients faced with a myeloproliferative neoplasm ...
Pharmaceutical Technology4d
Dexamethasone sodium phosphate by AVM Biotechnology for Metastatic Pancreatic Cancer: Likelihood of Approval
Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Metastatic Pancreatic Cancer.
Pharmaceutical Technology4d
Volrustomig by AstraZeneca for Malignant Neoplasms: Likelihood of Approval
Volrustomig is under clinical development by AstraZeneca and currently in Phase II for Malignant Neoplasms. According to GlobalData, Phase II drugs for Malignant Neoplasms does not have sufficient ...